Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps

Cancer Research

Volumn 62, Issue 2, 2002, Pages 506-511

  Seno, Hiroshi ^a,a   Oshima, Masanobu ^a   Ishikawa, Tomo O ^a   Oshima, Hiroko ^a   Takaku, Kazuaki ^a   Narumiya, Shuh ^a   Taketo, Makoto M ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; VASCULOTROPIN;

ADENOMATOUS POLYP; ANGIOGENESIS; ANIMAL MODEL; ARTICLE; COLON CARCINOGENESIS; COLORECTAL TUMOR; GENE MUTATION; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TUMOR GROWTH;

ADENOCARCINOMA; ADENOMA; ANIMALS; CYCLOOXYGENASE 2; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; INTESTINAL POLYPS; ISOENZYMES; LYMPHOKINES; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROSTAGLANDIN E; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037081194     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tumor angiogenesis: Past, present, and the near future
2. The hallmarks of cancer
3. Angiogenesis in cancer and other diseases
4. Tumor angiogenesis: Therapeutic implications
5. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
6. Induction of angiogenesis during the transition from hyperplasia to neoplasia
7. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
8. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
9. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
10. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
11. Gene expressed in human tumor endothelium
12. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene
13. Δ716 knockout mice
14. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
15. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
16. Cyclooxygenase-2 inhibitors in tumorigenesis (Part I)
17. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
18. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
19. 3
20. Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis
21. FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury
22. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene
23. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis
24. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
25. Molecular mechanisms of diverse actions of prostanoid receptors
26. Δ716 knockout mice
27. Suppression of intestinal polyposis by inhibition of cyclooxygenase-2 in a mouse model for familial adenomatous polyposis
28. 2 gene
29. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
30. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants
31. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
32. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences
33. 2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells
34. Host cyclooxygenase-2 modulates carcinorna growth
35. Fibroblast growth factors are required for efficient tumor angiogenesis
36. Role of HIF-1α in hypoxiamediated apoptosis, cell proliferation and tumour angiogenesis
37. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells
38. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element
39. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis